HK Stock MarketDetailed Quotes

02427 GUANZE MEDICAL

Watchlist
  • 1.000
  • 0.0000.00%
Market Closed Jun 3 16:08 CST
950.00MMarket Cap31.25P/E (TTM)

GUANZE MEDICAL Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(FY)Dec 31, 2018
Turnover
-11.88%156.07M
-24.55%74.41M
-16.09%177.11M
-7.60%98.62M
14.44%211.08M
10.49%106.73M
30.97%184.44M
--96.59M
7.78%140.83M
--130.66M
Operating income
-11.88%156.07M
-24.55%74.41M
-16.09%177.11M
-7.60%98.62M
14.44%211.08M
10.49%106.73M
30.97%184.44M
96.59M
7.78%140.83M
130.66M
Cost of sales
26.49%-70.67M
47.14%-31.18M
28.99%-96.14M
16.13%-59M
-10.19%-135.38M
-3.35%-70.34M
-30.13%-122.86M
---68.06M
0.96%-94.41M
---95.33M
Operating expenses
26.49%-70.67M
47.14%-31.18M
28.99%-96.14M
16.13%-59M
-10.19%-135.38M
-3.35%-70.34M
-30.13%-122.86M
-68.06M
0.96%-94.41M
-95.33M
Gross profit
5.47%85.41M
9.09%43.23M
6.97%80.98M
8.90%39.63M
22.94%75.7M
27.54%36.39M
32.66%61.58M
28.53M
31.35%46.42M
35.34M
Selling expenses
-13.16%-26.56M
-8.54%-13.3M
5.89%-23.47M
-5.41%-12.25M
-47.10%-24.94M
-24.49%-11.62M
-42.21%-16.96M
---9.34M
-0.28%-11.92M
---11.89M
Administrative expenses
47.87%-14.33M
0.12%-6.54M
-54.05%-27.5M
29.14%-6.55M
-360.26%-17.85M
-501.95%-9.25M
-9.92%-3.88M
---1.54M
12.09%-3.53M
---4.01M
Research and development expenses
-181.92%-1.53M
-296.76%-734K
-36.87%-542K
10.19%-185K
66.58%-396K
-68.85%-206K
12.80%-1.19M
---122K
43.45%-1.36M
---2.4M
Impairment and provision
-2,039.00%-4.28M
-1,008.06%-1.37M
-373.97%-200K
10.79%-124K
159.84%73K
-172.55%-139K
-17.31%-122K
---51K
-215.15%-104K
---33K
-Other impairment is provision
-2,039.00%-4.28M
-1,008.06%-1.37M
-373.97%-200K
10.79%-124K
159.84%73K
-172.55%-139K
-17.31%-122K
---51K
-215.15%-104K
---33K
Special items of operating profit
-53.18%809K
17.99%1.94M
61.50%1.73M
39.81%1.64M
198.05%1.07M
71.74%1.17M
145.89%359K
--683K
135.48%146K
--62K
Operating profit
27.48%39.51M
4.79%23.21M
-7.91%30.99M
35.52%22.15M
-15.43%33.65M
-10.03%16.35M
34.22%39.79M
18.17M
73.77%29.65M
17.06M
Financing cost
16.49%-861K
38.75%-403K
-72.70%-1.03M
-110.22%-658K
24.33%-597K
-5.74%-313K
-1,447.06%-789K
---296K
-628.57%-51K
---7K
Earning before tax
29.00%38.65M
6.12%22.81M
-9.36%29.96M
34.06%21.49M
-15.24%33.06M
-10.29%16.03M
31.79%39M
17.87M
73.55%29.6M
17.05M
Tax
8.12%-10.73M
-9.70%-6.68M
-16.89%-11.68M
-25.20%-6.09M
-0.29%-9.99M
-7.89%-4.87M
-36.98%-9.96M
---4.51M
-61.43%-7.27M
---4.5M
After-tax profit from continuing operations
52.70%27.92M
4.70%16.13M
-20.73%18.29M
37.92%15.4M
-20.57%23.07M
-16.43%11.17M
30.10%29.04M
13.36M
77.89%22.32M
12.55M
Earning after tax
52.70%27.92M
4.70%16.13M
-20.73%18.29M
37.92%15.4M
-20.57%23.07M
-16.43%11.17M
30.10%29.04M
13.36M
77.89%22.32M
12.55M
Minority profit
3.80%355K
106.98%178K
157.14%342K
19.44%86K
--133K
--72K
----
----
----
----
Profit attributable to shareholders
53.63%27.57M
4.13%15.95M
-21.76%17.94M
38.04%15.32M
-21.03%22.94M
-16.97%11.1M
30.10%29.04M
13.36M
77.89%22.32M
12.55M
Basic earnings per share
50.00%0.03
0.00%0.02
-33.33%0.02
0.02
0.03
Diluted earnings per share
0.00%0.02
0.02
0.03
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Auditor
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
Ernst & Young
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(FY)Dec 31, 2018
Turnover -11.88%156.07M-24.55%74.41M-16.09%177.11M-7.60%98.62M14.44%211.08M10.49%106.73M30.97%184.44M--96.59M7.78%140.83M--130.66M
Operating income -11.88%156.07M-24.55%74.41M-16.09%177.11M-7.60%98.62M14.44%211.08M10.49%106.73M30.97%184.44M96.59M7.78%140.83M130.66M
Cost of sales 26.49%-70.67M47.14%-31.18M28.99%-96.14M16.13%-59M-10.19%-135.38M-3.35%-70.34M-30.13%-122.86M---68.06M0.96%-94.41M---95.33M
Operating expenses 26.49%-70.67M47.14%-31.18M28.99%-96.14M16.13%-59M-10.19%-135.38M-3.35%-70.34M-30.13%-122.86M-68.06M0.96%-94.41M-95.33M
Gross profit 5.47%85.41M9.09%43.23M6.97%80.98M8.90%39.63M22.94%75.7M27.54%36.39M32.66%61.58M28.53M31.35%46.42M35.34M
Selling expenses -13.16%-26.56M-8.54%-13.3M5.89%-23.47M-5.41%-12.25M-47.10%-24.94M-24.49%-11.62M-42.21%-16.96M---9.34M-0.28%-11.92M---11.89M
Administrative expenses 47.87%-14.33M0.12%-6.54M-54.05%-27.5M29.14%-6.55M-360.26%-17.85M-501.95%-9.25M-9.92%-3.88M---1.54M12.09%-3.53M---4.01M
Research and development expenses -181.92%-1.53M-296.76%-734K-36.87%-542K10.19%-185K66.58%-396K-68.85%-206K12.80%-1.19M---122K43.45%-1.36M---2.4M
Impairment and provision -2,039.00%-4.28M-1,008.06%-1.37M-373.97%-200K10.79%-124K159.84%73K-172.55%-139K-17.31%-122K---51K-215.15%-104K---33K
-Other impairment is provision -2,039.00%-4.28M-1,008.06%-1.37M-373.97%-200K10.79%-124K159.84%73K-172.55%-139K-17.31%-122K---51K-215.15%-104K---33K
Special items of operating profit -53.18%809K17.99%1.94M61.50%1.73M39.81%1.64M198.05%1.07M71.74%1.17M145.89%359K--683K135.48%146K--62K
Operating profit 27.48%39.51M4.79%23.21M-7.91%30.99M35.52%22.15M-15.43%33.65M-10.03%16.35M34.22%39.79M18.17M73.77%29.65M17.06M
Financing cost 16.49%-861K38.75%-403K-72.70%-1.03M-110.22%-658K24.33%-597K-5.74%-313K-1,447.06%-789K---296K-628.57%-51K---7K
Earning before tax 29.00%38.65M6.12%22.81M-9.36%29.96M34.06%21.49M-15.24%33.06M-10.29%16.03M31.79%39M17.87M73.55%29.6M17.05M
Tax 8.12%-10.73M-9.70%-6.68M-16.89%-11.68M-25.20%-6.09M-0.29%-9.99M-7.89%-4.87M-36.98%-9.96M---4.51M-61.43%-7.27M---4.5M
After-tax profit from continuing operations 52.70%27.92M4.70%16.13M-20.73%18.29M37.92%15.4M-20.57%23.07M-16.43%11.17M30.10%29.04M13.36M77.89%22.32M12.55M
Earning after tax 52.70%27.92M4.70%16.13M-20.73%18.29M37.92%15.4M-20.57%23.07M-16.43%11.17M30.10%29.04M13.36M77.89%22.32M12.55M
Minority profit 3.80%355K106.98%178K157.14%342K19.44%86K--133K--72K----------------
Profit attributable to shareholders 53.63%27.57M4.13%15.95M-21.76%17.94M38.04%15.32M-21.03%22.94M-16.97%11.1M30.10%29.04M13.36M77.89%22.32M12.55M
Basic earnings per share 50.00%0.030.00%0.02-33.33%0.020.020.03
Diluted earnings per share 0.00%0.020.020.03
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified OpinionUnqualified Opinion
Auditor Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & YoungErnst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg